Deargen Partners with Serengen for Joint Service Partnership in AI-Enhanced Drug Discovery
Deargen Partners with Serengen to Revolutionize Drug Development Artificial Intelligence-based Pharmatech company, Deargen, has announced a game-changing collaboration with German DNA Encoded Library (DEL) company, Serengen. This joint service partnership aims to enhance and expedite the process of discovering effective substances for new drug development. DEL, a compound library that merges genetic barcodes with organic […]
